Follow Us On

Facebook  X  Linkedin  YouTube
 
 
 

ABIPP Certification:


The 31.5 CME credits available through the TOBI Regenerative Medicine Review Course Webinar, Hands-On Cadaver Lab, and 2-Day Symposium meet the certification requirements for the American Board of Interventional Pain Physicians (ABIPP) competency certification in regenerative medicine.


To apply for this certification, please visit abipp.org to submit the necessary documentation.

Non-Partisan Proposal for Reforming Physician Payment System and Preserving Telehealth Services



Physician payments have declined significantly due to budget neutrality rules and reimbursement cuts. Since 2001, Medicare payments to physicians have dropped by 33% when adjusted for inflation. These reductions have been compounded by 2% annual sequestration cuts introduced after the Affordable Care Act (ACA), which continues through 2032. Despite their long-term impact, sequestration cuts receive little public attention.


Congress has historically delayed or softened these cuts. However, in 2025, a bill that would have adjusted payment rates was removed from the continuing resolution, resulting in continued reductions. Meanwhile, insurance premiums have risen nearly 400%, highlighting the disparity between healthcare costs and physician compensation.

Ironically, while physicians face significant payment cuts, the Centers for Medicare & Medicaid Services (CMS) proposed on January 10, 2025, a 4.3% payment increase for Medicare Advantage plans, totaling $21 billion in 2026 and an estimated $210 billion over the following decade starting in calendar year 2026. This proposal comes amid ongoing concerns about Medicare Advantage overpayments, estimated at nearly $100 billion annually, and additional funding through annual premiums of $198 from all Medicare beneficiaries, amounting to roughly $13 billion per year.


In response, the American Society of Interventional Pain Physicians (ASIPP) submitted a nonpartisan reform proposal advocating for telehealth protections and elimination of sequester cuts - measures that have received strong bipartisan support in Congress.


Both the House of Representatives and the Senate voted to pass a reconciliation bill, nicknamed the “Big Beautiful Bill”, which has been signed into law by the President recently. It proposes an $8.9 billion investment in the Medicare Physician Fee Schedule, with a 2.25% update in 2026.


The proposal does not address the budget neutrality provision, growing practice costs, inflationary pressures, or ongoing sequestration and pay-as-you-go (PAYGO) cuts. It also fails to resolve issues with the Medicare Access and CHIP Reauthorization Act (MACRA), particularly within the Merit-Based Incentive Payment System (MIPS).


On November 1, 2024, CMS finalized a 2.8% cut to physician payments, an estimated $20 billion, while also eliminating telehealth services. These cuts continue to threaten physician sustainability and patient access to care.


Click here to read the full Pain Physician journal article.

A Statement from FDA Commissioner Marty Makary, MD, MPH:

Announcing Resolution of the IV Saline Solutions Shortage



I am pleased to announce that the nationwide shortage of sodium chloride 0.9% injection products, a form of intravenous (IV) saline, has officially ended. This marks a significant milestone for public health and reinforces the FDA’s commitment to ensuring Americans have consistent access to life-saving medical products.


This success is the result of close collaboration between the FDA, the Administration for Strategic Preparedness and Response, and our industry partners, who worked swiftly and strategically to expand manufacturing capacity and restore stability to the supply chain. Their responsiveness and innovation have been vital to this achievement. In addition, the FDA used its available regulatory tools to help increase supplies available to hospitals to help meet patient needs. For example, the FDA conducted scientific and regulatory assessments to help facilitate the temporary importation of intravenous solutions and expedited reviews to increase manufacturing capacities and extend product expiry.


The shortage of sodium chloride 0.9% injection products has resolved, and therefore these products will be removed from the FDA list of Current Shortages in the Drug Shortage Database on the FDA website. We generally recommend hospitals, health systems, and clinics use the FDA-approved drug when available.


Click here to read the full statement.

JOIN or RENEW your ASIPP Membership for the best registration rates.

Billions in profits, millions in unpaid claims: Medicaid insurers leave Illinois providers struggling, patients losing care


Small clinics and hospitals are drowning in denied and delayed claims from Illinois Medicaid managed care organizations. To cope, some have stopped accepting Medicaid altogether. Meanwhile, MCOs see increasing profits, but aren’t meeting patient care metrics.


On a weekend night, long after her last patient had gone home, Crystal Stone sat at her desk at New Leaf Behavioral Health, sifting through a growing stack of unpaid Medicaid claims. The numbers didn’t add up. They never did. One denial after another — each one another threadbare explanation that left her clinic unpaid.


She should have been resting, spending time with her family, but instead, she was battling insurance companies for money she had already earned.


Click here to read the full article.

When Is CPAP Associated With

Cardiovascular Benefit ... vs Harm?

Pooled analysis suggests differential cardiovascular effects of CPAP

Key Takeaways


• In a pooled analysis of three randomized trials, CPAP had overall null cardiovascular effects in patients with obstructive sleep apnea and cardiovascular disease.


• However, CPAP leaned toward benefit in those with high-risk sleep apnea, and potential harm in those with low-risk sleep apnea.



• Assessment of sleep apnea phenotype may thus identify patients likely to have a cardiovascular benefit with CPAP.

Cardiovascular benefits and harms could be detected with continuous positive airway pressure (CPAP) treatment for select patients with obstructive sleep apnea (OSA), a pooled analysis of major randomized trials showed.


Without stratifying by OSA phenotype, there remained no secondary cardiovascular effects in the RICCADSA, ISAACC, and SAVE studies -- individually and pooled together -- in patients with concomitant cardiovascular disease (CVD).


Click here to read the full article.

Our Sponsor

Our Sponsor

Tamiflu Findings Raise Questions

About Drug Label Warning for Kids

Flu itself, not oseltamivir, was tied to serious neuropsychiatric events, analysis suggests

 

Key Takeaways


• Compared with untreated flu, oseltamivir treatment reduced the risk of serious neuropsychiatric events in children.


• Prescribing information for oseltamivir carries warning about abnormal behavior in kids with flu based on case reports.


• Concerns about possible side effects may contribute to oseltabmivir being underused in kids at high risk for flu complications.

Treatment with the antiviral oseltamivir (Tamiflu) was tied to a reduced risk of serious neuropsychiatric events in children and adolescents, an analysis of Medicaid beneficiaries in Tennessee suggested.


Compared with untreated flu, the risk of serious neuropsychiatric events was lower in kids treated with oseltamivir during flu exposure periods and post-treatment periods, reported James Antoon, MD, PhD, MPH, of Vanderbilt University Medical Center in Nashville, Tennessee and colleagues.


Click here to read the full article.


New Dates Just Announced

Mark your calendars!



August 30, September 27, October 25,

November 15, & December 13


  • ABIPP Part I

Four (4) hour virtual exam


  • ABIPP Path – Combined CCPM/ CSM Exam

For those with subspecialty in Pain Medicine

Two (2) hour virtual exam


  • ABIPP Competency Exam in IPM

For those without primary board certification

Two (2) hour virtual exam


  • ABIPP Competency Exam in Regenerative Medicine

Two (2) hour virtual exam


  • Controlled Substance Management Competency Exam

Two (2) hour virtual exam


  • Documentation, Coding, Compliance, Practice Management Competency Exam

Two (2) hour virtual exam

Exam Dates




Novel Tool May Predict NSAID Hypersensitivity




A new risk stratification tool known as CA4TCH — which relies solely on clinical history — could help predict which patients with a suspected hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) will have a hypersensitivity confirmed during a drug provocation test.


METHODOLOGY:

  • To develop and validate CA4TCH, researchers conducted a retrospective study of 1035 patients who presented with suspected NSAID hypersensitivity at the allergy unit of the University Hospital of Montpellier in Montpellier, France, between February 2001 and December 2020 and underwent drug provocation testing.
  • Using elements of the clinical history — including sex; age at the last reaction; reaction onset ≤ 24 hours; whether the last reaction occurred in the past 5 years; history of anaphylaxis or respiratory symptoms; reactions to two or more drug classes; reaction to aspirin; and comorbid atopy, asthma, sinus disease, or chronic spontaneous urticaria — the team constructed a risk score to predict the presence of a drug hypersensitivity reaction.
  • They then validated the risk score in an independent cohort of 69 participants from the University Hospital of Tours, Tours, France.


Click here to read the full article.

 

We're excited to let you know that the new ASIPP Community, hosted by DocMatter, is now live!


The ASIPP Community on DocMatter will serve as a place for members to collaborate around clinical and research topics to advance the care of their interventional pain patients.


Click here to be a part of the conversation!

Pain Medicine Case Reports (PMCR) and Editor-in-Chief Alaa Abd-Elsayed, MD, PhD would like to invite you to submit case reports and case series to the PMCR journal. Your article will be published free of charge.


Open access journals are freely available online for immediate worldwide open access to the full text of published articles. There is no subscription fee for open access journals. Open access journals are no different from traditional subscription-based journals: they undergo the same peer review and quality control as any other scholarly journal.


Interested in becoming a member of the PMCR Editorial Board?

Editorial board members are asked to review 2-6 manuscripts per year. Please submit your most up-to-date CV to sgold@asipp.org for consideration.


For more information or to submit your articles, click here.

We are excited to announce that Pain Medicine Case Reports (PMCR) journal (eISSN 2768-5152) has been accepted for inclusion in MEDLINE and PubMed, the prestigious bibliographic database of the U.S. National Library of Medicine. PMCR, a companion publication to the prestigious Pain Physician journal by ASIPP, joins its counterpart in achieving indexing in both MEDLINE and PubMed, marking ASIPP’s dual presence in these renowned databases.


The inclusion of PMCR journal in MEDLINE signifies a higher level of selectivity, as MEDLINE consists of the top 5,200 biomedical journals. This indexing also means that articles from PMCR will be searchable using NLM Medical Subject Headings (MeSH terms) and other metadata.


The selection for MEDLINE follows a rigorous evaluation process by reviewers from the Literature Selection Technical Review Committee (LSTRC). According to their criteria, the scientific quality of a journal’s content is the primary factor considered for indexing.


We extend our congratulations to the Pain Medicine Case Reports Editor-in-Chief, Deputy Editor-in-Chief, Journal Team, and Editorial Board for this achievement, which underscores the significance and excellence of this esteemed journal.

 

CASE REPORTS

Epidural Hematoma in an Elderly Patient With Multiple Comorbidities on Aspirin Following Spinal Cord Stimulator Trial: A Case Report


Samer Hajmurad, DO, Karim Jandali Rifai, BS, Adryan Alexander Perez, MD, and Andrew Hall, MD

 

Thoracic Spinal Cord Compression Precipitated by Epidural Steroid Injection Due to Undiagnosed Dural Arteriovenous Fistula – A Case Report


Stephen N. Dunay, MD, John Wainwright, MD, Ammar Siddiqui, MD, and Gurmeen Kaur, MBBS

 
 

New Issue Now Available!

 

GUIDELINES

Diagnostic Guidance for Chronic Complex Regional Pain Syndrome Type I and Type II from The American Society of Interventional Physicians (ASIPP)


Christopher Gharibo, MD, Miles Day, MD, Steve M. Aydin, DO, Alan D. Kaye, MD, PhD, Salahadin Abdi, MD, PhD, Sudhir Diwan, MD, Lisa V. Doan, MD, Danielle Feng, MD, Kris Ferguson, MD, Kirolos Georges, MD, Andrew Kaufman, MD, Nebojsa Nick Knezevic, MD, PhD, Sean Li, MD, Franzes A. Liongson, MD, Devi Nampiaparampil, MD, Annu Navani, MD, Mahendra Sanapati, MD, Michael E. Schatman, PhD, Amol Soin, MD, Peter S. Staats, MD, Giustino Varrassi, MD, PhD, Jing Wang, MD, PhD, and Laxmaiah Manchikanti, MD

 

HEALTH POLICY REVIEW

Non-Partisan Proposal for Reforming Physician Payment System and Preserving Telehealth Services


Laxmaiah Manchikanti, MD, Paul J. Hubbell, III, MD, Ramarao Pasupuleti, MD, Ann Conn, MD, and Mahendra Sanapati, MD




ASIPP is in collaboration with Curi Medical Liability Program




Since this malpractice insurance program officially launched in November 2018, ASIPP has signed up hundreds of providers with an average savings of 30%. This is professional liability insurance tailored to our specialty and will stand up for us and defend our practices. 

 

Curi is a full-service advisory firm that serves physicians and their practices. Their valued advice is grounded in your priorities and elevated in your outcomes. They are driven by a deep understanding of your specific circumstances in medicine, business, and life. To read a few important points to keep in mind about the program, including discounts, administrative defense, cyber coverage, aggressive claims handling, and complimentary risk management CME activities, visit our website.


IMPORTANT UPDATE

SPRINT no longer misclassified as PNT 



SPR is happy to announce an important update regarding Humana Medicare Advantage. As of May 1, Humana is now recognizing SPRINT as a PNS therapy. Previously, SPRINT was categorized as PNT (Percutaneous Nerve Stimulation), which allowed denials on the grounds that the therapy fell outside the NCD.


Additional details are as follows:

Payer: Humana Medicare Advantage (click here to view policy)

Policy Title: Peripheral Nerve Stimulators

Policy changes: SPRINT no longer misclassified as PNT and is now appropriately classified as PNS. Humana is applying the Noridian Medicare LCD criteria to ALL PNS devices – Including SPRINT PNS!

Effective Date: 5/1/2025


Click here to view a PDF of the official policy update.

 

Group Purchasing Organization Offer Better Pricing and Creates Added Value


ASIPP has formed a partnership with Henry Schein and PedsPal, a national GPO that has a successful history of negotiating better prices on medical supplies and creating value-added services for independent physicians. Working with MedAssets, PedsPal provides excellent pricing on products like contrast media that alleviate some of the financial pressures you experience today.



Learn More


For updated information concerning tariffs on products, click here.

 
 

ASIPP, Fedora Healthcare Solutions Partnership


ASIPP offers our members the benefit of a unique revenue cycle management/ billing service.



We have received a tremendous amount of interest in the ASIPP billing and coding program.




Click here to learn more about the negotiated rate for practices and more!

Like and Follow ASIPP® on Facebook, X, LinkedIn,

and YouTube for the most up-to-date news

related to you, your practice, and your patients!